1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Chamberlin, S.G. Brennan, L. Puddicombe, S.M. Davies, D.E. Turner, D.L. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 268 6247 10.1046/J.0014-2956.2001.02581.X 11733021 Solution Structure of the Megf/Tgfalpha44-50 Chimeric Growth Factor. 2001 US J.Biol.Chem. JBCHA3 0071 0021-9258 271 30392 10.1074/JBC.271.48.30392 8940002 The Interaction of an Epidermal Growth Factor/ Transforming Growth Factor Alpha Tail Chimera with the Human Epidermal Growth Factor Receptor Reveals Unexpected Complexities 1996 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 THE PROTEIN IS A CHIMERA OF EPIDERMAL GROWTH FACTOR RESIDUES 977-1018 AND HUMAN TRANSFORMING GROWTH FACTOR ALPHA RESIDUES 83-89,THE PROTEIN IS A CHIMERA OF EPIDERMAL GROWTH FACTOR RESIDUES 977-1018 AND HUMAN TRANSFORMING GROWTH FACTOR ALPHA RESIDUES 83-89 5257.785 Pro-epidermal growth factor,Protransforming growth factor alpha UNP residues 977-1018,UNP residues 83-89 1 man polymer EGF no no NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCEHADLLA NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRCEHADLLA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n House Mouse Pichia pastoris sample 1 42 Egf 10090 Mus musculus 4922 Komagataella pastoris pPIC9 Plasmid Biological sequence Human Pichia pastoris sample 43 49 TGFA 9606 Homo sapiens 4922 Komagataella pastoris pPIC9 Plasmid Biological sequence entity entity_name_com entity_src_gen entity_src_nat struct_ref repository Initial release Version format compliance Version format compliance Data collection Database references Source and taxonomy Structure summary 1 0 2002-08-08 1 1 2011-05-08 1 2 2011-07-13 1 3 2018-03-28 _entity.details _entity.pdbx_description _entity.pdbx_fragment _entity.src_method _entity_name_com.name _struct_ref.pdbx_align_begin _struct_ref.pdbx_seq_one_letter_code PDBE Y PDBE 2001-08-08 REL LEAST RESTRAINT VIOLATION 50 10 2D-1H-NOESY 2D-1H-TOCSY 2D-1H-COSY 3.0 pH 298 K TORSION ANGLE DYNAMICS WITH SIMULATED ANNEALING 1 BRENNAN L, TURNER DL, MESSIAS AM, TEODORO ML, LEGALL J, SANTOS H, XAVIER AX. refinement INDYANA structure solution INDYANA 500 Varian VXR500 ASN 1 n 1 ASN 1 A SER 2 n 2 SER 2 A TYR 3 n 3 TYR 3 A PRO 4 n 4 PRO 4 A GLY 5 n 5 GLY 5 A CYS 6 n 6 CYS 6 A PRO 7 n 7 PRO 7 A SER 8 n 8 SER 8 A SER 9 n 9 SER 9 A TYR 10 n 10 TYR 10 A ASP 11 n 11 ASP 11 A GLY 12 n 12 GLY 12 A TYR 13 n 13 TYR 13 A CYS 14 n 14 CYS 14 A LEU 15 n 15 LEU 15 A ASN 16 n 16 ASN 16 A GLY 17 n 17 GLY 17 A GLY 18 n 18 GLY 18 A VAL 19 n 19 VAL 19 A CYS 20 n 20 CYS 20 A MET 21 n 21 MET 21 A HIS 22 n 22 HIS 22 A ILE 23 n 23 ILE 23 A GLU 24 n 24 GLU 24 A SER 25 n 25 SER 25 A LEU 26 n 26 LEU 26 A ASP 27 n 27 ASP 27 A SER 28 n 28 SER 28 A TYR 29 n 29 TYR 29 A THR 30 n 30 THR 30 A CYS 31 n 31 CYS 31 A ASN 32 n 32 ASN 32 A CYS 33 n 33 CYS 33 A VAL 34 n 34 VAL 34 A ILE 35 n 35 ILE 35 A GLY 36 n 36 GLY 36 A TYR 37 n 37 TYR 37 A SER 38 n 38 SER 38 A GLY 39 n 39 GLY 39 A ASP 40 n 40 ASP 40 A ARG 41 n 41 ARG 41 A CYS 42 n 42 CYS 42 A GLU 43 n 43 GLU 43 A HIS 44 n 44 HIS 44 A ALA 45 n 45 ALA 45 A ASP 46 n 46 ASP 46 A LEU 47 n 47 LEU 47 A LEU 48 n 48 LEU 48 A ALA 49 n 49 ALA 49 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N ILE 23 A N ILE 23 A O SER 28 A O SER 28 1 A A HG H SER LEU 25 26 1.03 1 A A HG H SER TYR 28 29 1.30 3 A A HD11 H LEU LEU 47 48 1.33 4 A A HG H SER LEU 25 26 1.10 8 A A O HH21 GLY ARG 12 41 1.53 1 A ASP 11 77.15 65.22 1 A ASN 16 45.49 86.28 1 A SER 25 -63.67 -83.33 1 A SER 38 -152.19 -32.19 1 A CYS 42 43.93 27.72 1 A ASP 46 -113.21 53.20 2 A TYR 3 -169.46 -42.21 2 A CYS 6 -55.13 170.04 2 A ASP 11 77.77 57.97 2 A ASN 16 44.63 85.72 2 A SER 25 -62.03 -83.17 2 A SER 38 -151.19 -23.20 2 A CYS 42 46.54 28.13 2 A ASP 46 -109.52 54.11 3 A ASP 11 77.15 65.38 3 A ASN 16 44.20 85.58 3 A SER 25 -64.25 -82.39 3 A SER 38 -148.50 -34.13 3 A ASP 40 -38.65 119.63 3 A CYS 42 44.84 29.21 3 A HIS 44 -55.93 94.57 4 A SER 2 -171.23 -26.04 4 A TYR 3 -169.96 60.99 4 A ASP 11 77.09 83.45 4 A ASN 16 43.85 84.64 4 A SER 25 -67.42 -81.75 4 A ASP 46 -146.56 52.04 4 A LEU 48 -147.85 -61.03 5 A SER 2 175.37 -22.73 5 A ASP 11 76.86 57.38 5 A ASN 16 45.87 86.91 5 A SER 25 -62.31 -83.11 5 A SER 38 -139.35 -154.03 5 A CYS 42 42.42 22.63 5 A HIS 44 -56.56 91.95 5 A ASP 46 -140.89 52.40 6 A ASP 11 77.34 64.31 6 A ASN 16 49.33 89.12 6 A MET 21 -166.33 97.48 6 A SER 25 -66.00 -76.42 6 A SER 38 -143.40 -157.53 6 A ASP 40 -58.21 108.43 6 A HIS 44 -65.55 96.18 6 A ASP 46 -143.03 53.09 6 A LEU 47 -77.42 28.64 6 A LEU 48 62.13 96.67 7 A SER 2 -171.79 27.85 7 A ASP 11 77.10 56.63 7 A ASN 16 46.73 86.39 7 A SER 25 -64.16 -83.25 7 A ASP 46 -142.94 55.97 7 A LEU 48 -176.50 24.33 8 A ASP 11 77.23 81.33 8 A ASN 16 42.63 83.64 8 A SER 25 -66.20 -77.54 8 A ASN 32 -106.86 79.77 8 A SER 38 -154.19 -32.37 8 A ASP 40 -39.54 122.73 9 A PRO 4 -35.61 138.41 9 A ASP 11 74.76 59.99 9 A ASN 16 46.02 86.46 9 A SER 25 -65.34 -81.82 9 A SER 38 -173.80 -16.00 9 A ASP 40 42.80 85.70 9 A CYS 42 42.47 23.22 9 A GLU 43 -69.99 -70.63 9 A ASP 46 -119.86 54.25 9 A LEU 47 -60.12 -179.54 10 A TYR 3 -159.79 87.66 10 A PRO 4 -49.53 -7.38 10 A ASP 11 76.80 56.59 10 A ASN 16 46.55 87.87 10 A MET 21 -151.31 88.09 10 A SER 25 -69.73 -78.65 10 A HIS 44 -62.24 90.58 10 A ASP 46 -142.40 54.26 MEGF/TGFALPHA44-50 CHIMERA Solution Structure the mEGF/TGFalpha44-50 chimeric growth factor 1 N N A GLY 39 A GLY 39 HELX_P A GLU 43 A GLU 43 5 1 5 disulf 2.011 A CYS 6 A SG CYS 6 1_555 A CYS 20 A SG CYS 20 1_555 disulf 2.017 A CYS 14 A SG CYS 14 1_555 A CYS 31 A SG CYS 31 1_555 disulf 2.016 A CYS 33 A SG CYS 33 1_555 A CYS 42 A SG CYS 42 1_555 GROWTH FACTOR GROWTH FACTOR, EGF GROWTH FACTOR, CHIMERIC EGF_MOUSE UNP 1 977 P01132 NSYPGCPSSYDGYCLNGGVCMHIESLDSYTCNCVIGYSGDRC TGFA_HUMAN UNP 1 83 P01135 EHADLLA 977 1018 1GK5 1 42 P01132 A 1 1 42 83 89 1GK5 43 49 P01135 A 2 43 49 2 anti-parallel A VAL 19 A VAL 19 A ILE 23 A ILE 23 A SER 28 A SER 28 A ASN 32 A ASN 32 1 P 1